DWP16001 Amg

DRUG2 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

T2DM (Type 2 Diabetes Mellitus)

Phase 3

The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus

CompletedNCT04654390

Daewoong Pharmaceutical Co. LTD.T2DM (Type 2 Diabetes Mellitus)

Start: 2020-12-30End: 2021-12-17Updated: 2022-04-01

Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.

CompletedNCT05376930

Daewoong Pharmaceutical Co. LTD.T2DM (Type 2 Diabetes Mellitus)

Start: 2021-09-16End: 2022-05-31Updated: 2022-10-25